Intchains Group
ICG
BIGG DIGITAL ASSETS INC
BBKCF
NEPTUNE DIGITAL ASSETS CORP
NPPTF
Bitdeer Technologies
BTDR
FRMO CORP
FRMO
Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.